Now live: European new issue coverage and historical data, for free. → Explore All Content & Delivery Channels
Log In
No results found for "".

Deal Details

C/PIndustryStatusTicker(s)Issuer(s)Size(m)TranchesRegionDate
IGC
HLTH
PRCD
ZBH
Zimmer Biomet Holdings Inc€500
1USOA
Nov 5, 2026
currency
EUR
size (m)
500.000
maturity
Nov 12, 2033
type
Fixed
tenor
7.000
call
-
registration
SEC Registered
benchmark
Swaps
ranking
Sr. Unsecured
moody's
Baa2
s&p
BBB
fitch
BBB
size description
Will Not Grow
re-open/tap
No
ipt
MS+135-140
ipt-pxd
-30.5
guidance
STL
spread
107
coupon
4.375%
spread set
-
price
99.99400
yield
4.376%
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
7
billing & delivering
active leads
BRC, CTI, HSB, MOS, ...
joint leads
BAM, BNP, DCR, GSC, ...
passive leads
-
co-managers
coordinating managers
-
book size (m)
-
peak book (m)
-
x-covered
-
book attrition
-
nic
7
billing & delivering
active leads
BRC, CTI, HSB, MOS, ...
joint leads
BAM, BNP, DCR, GSC, ...
passive leads
-
co-managers
coordinating managers
-
Tranche Comments
First Pay: 2027-11-12; Registration: SEC Registered; Comments: DBR 3.300% due 15 November 2033 (100.830 bid) + 121.1bps | HR 95%. MWC: B+20. Tax Call: Yes. CoC: Yes. LEI: 2P2YLDVPES3BXQ1FRB91;
Use of Proceeds
General corporate purposes, which may include the repayment of other indebtedness (which could include a portion of the Issuer’s 2.425% notes due 2026 and/or a portion of the Issuer’s 4.700% notes due 2027), share repurchases, financing capital commitments and financing acquisitions. The Issuer may, including in the near term, also pursue one or more additional debt capital markets transactions, the proceeds of which may be used for general corporate purposes, which may include the repayment of a portion of the Issuer’s 2.425% notes due 2026 and/or a portion of the Issuer’s 4.700% notes due 2027
Relative Value

7yr (Nov 2033) @ MS+135-140

Implied Spread for fresh 7yr @ MS+100
Priced at MS+107
NIC of +7

We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.
By continuing, you agree to FINSIGHT's Terms of Use and Privacy Policy.